Supa Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.25 M
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
About Supa Biotech
Supa Biotech Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 April 1999 and has a history of 25 years and ten months. Its registered office is in Uttaranchal, Uttarakhand.
The Company is engaged in the Musical Instruments Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.25 M, as per Ministry of Corporate Affairs (MCA) records.
Girish Sah, Binita Shah, and Kiran Sah serve as directors at the Company.
Company Details
- Location Uttaranchal, Uttarakhand
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01134UR1999PTC024356
- Company No.
024356
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
What products or services does Supa Biotech Private Limited offer?
Supa Biotech Private Limited offers a wide range of products and services, including Bio Insecticides, Fertilizer, Soil Conditioner, Household Insecticides, Pest Repeller, Plant Growth Promoters.
Who are the key members and board of directors at Supa Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Binita Shah  | Managing Director | 01-Dec-1999 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Girish Sah | Whole-Time Director | 21-Jan-2003 | Current |
| Kiran Sah | Director | 01-Apr-2003 | Current |
Financial Performance of Supa Biotech.
Supa Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Supa Biotech?
In 2017, Supa Biotech had a promoter holding of 39.68% and a public holding of 60.32%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
The Nainital Bank LimitedBinita Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Supa Biotech?
Supa Biotech has a workforce of 16 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supa Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supa Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
